证券代码：688755 证券简称：汉邦科技 公告编号：2025-012 江苏汉邦科技股份有限公司 第一届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 江苏汉邦科技股份有限公司（以下简称"汉邦科技"或"公司"）第一届董 事会第二十一次会议于 2025 年 7 月 15 日以现场和通讯相结合的方式在公司会议 室召开，会议通知于 2025 年 7 月 11 日通过通讯方式送达全体董事。本次会议由 董事长张大兵先生召集并主持，会议应出席董事 9 人，实际出席董事 9 人，公司 监事和高级管理人员列席了会议。本次会议的召集、召开和表决程序符合《中华 人民共和国公司法》（以下简称"《公司法》"）等法律、法规和《公司章程》 的有关规定。 二、董事会会议审议情况 （一）审议通过了《关于变更公司注册资本、公司类型、经营范围、取消 监事会、监事设置、修订<公司章程>及其附件的议案》 公司董事会同意根据公司首次公开发行股票并在上海证券交易所科创板上 市的实际情况，将公司注册资本由人民币 6 ...

Core Viewpoint - Suzhou has launched two major funds, the "Billion Talent Fund" and the "Major Industry Development Fund," each with a total scale of 10 billion yuan, aimed at supporting talent and industrial development in the region [1][3]. Group 1: Billion Talent Fund - The "Billion Talent Fund," initiated by Suzhou Chuangtou Group, has a total scale of 10 billion yuan, with an initial phase of 2.5 billion yuan and a duration of 15 years [3]. - The fund will focus on key areas such as artificial intelligence, low-altitude economy, biomedicine, cultural creativity, and youth entrepreneurship, providing a comprehensive financial support system for talent development [3]. - Suzhou Chuangtou Group plans to establish 10 sub-funds within the year, with a specific focus on early-stage projects for talents under 35 years old [3]. Group 2: Major Industry Development Fund - The Major Industry Development Fund, led by Suzhou Guotou Group, also has a total scale of 10 billion yuan, focusing on "chain master" projects in significant industrial sectors [3][4]. - Investments will primarily be direct, with a minimum investment of 500 million yuan per project, targeting key enterprises that possess scarce resources and core technologies [4]. Group 3: Investment Trends and Achievements - Suzhou has seen a surge in successful IPOs from companies backed by its state-owned capital, with multiple firms going public in 2023, indicating a robust investment environment [5]. - The establishment of various specialized funds, including a 100 billion yuan biomedicine fund and a 50 billion yuan new energy fund, reflects Suzhou's commitment to enhancing its advantageous industries [6]. - The "New Billion" fund group is designed to cover all stages of enterprise growth, from incubation to maturity, with a total of 145 funds managed by Suzhou, exceeding 260 billion yuan in scale [8]. Group 4: Ecosystem and Future Outlook - Suzhou is recognized as a leading city in venture capital, with a clear strategy to optimize its industrial layout around the "1030" industrial system, which includes 10 key industrial clusters and 30 key industrial chains [9]. - The province of Jiangsu is also accelerating its mother fund layout, with a total scale of 500 billion yuan for strategic emerging industries, indicating a strong commitment to fostering innovation and investment [10][11]. - The collaborative approach of provincial and municipal funds aims to create a comprehensive investment ecosystem that supports various sectors and enhances regional competitiveness [17][18].

证券代码：688755 证券简称：汉邦科技 公告编号：2025-011 江苏汉邦科技股份有限公司 关于开立募集资金现金管理产品专用结算账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 3、公司财务部相关人员将及时分析和跟踪投资产品的投向、项目进展情况， 如评估发现存在可能影响公司资金安全的风险因素，将及时采取相应保全措施， 控制理财风险。 4、公司监事会、独立董事、董事会审计委员会有权对资金使用情况进行监督 与检查，必要时可以聘请专业机构进行审计。 三、对公司的影响 一、开立募集资金现金管理专用结算账户的情况 为提高募集资金使用效率，合理利用部分暂时闲置募集资金，子公司江苏汉 凰科技有限公司于近日开立了募集资金现金管理专用结算账户，具体账户信息如 下： | 账户名称 | 开户机构 | 资金账号 | | --- | --- | --- | | 江苏汉凰科技有限 | 江苏银行股份有限公司淮安 | 10300181000113506 | | 公司 | 华淮支行 | | 根据《上市公司募集资金监管规则》《上海证券交易所科 ...

Core Viewpoint - The company has approved the use of temporarily idle raised funds for cash management, ensuring that it does not affect normal operations or investment plans [2][3]. Group 1: Fund Management - The company plans to use up to RMB 398 million (39,800.00 thousand) of temporarily idle raised funds for cash management, focusing on safe and liquid principal-protected products [2]. - A special settlement account for cash management has been opened to enhance the efficiency of fund usage [2]. - The accounts are specifically designated for cash management and will not be used for non-raised funds or other purposes [2][3]. Group 2: Risk Control Measures - The company will adhere to relevant regulations and internal policies when conducting cash management activities [3]. - Measures will be taken to safeguard fund security, including potential audits by professional institutions if risks are identified [3]. Group 3: Impact on the Company - The cash management initiative will not affect the implementation of investment projects or the normal turnover of funds [3]. - This strategy aims to improve the efficiency of fund usage and increase returns on cash assets for the company and its shareholders [3].

江苏汉邦科技股份有限公司 关于开立募集资金现金管理产品专用结算账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏汉邦科技股份有限公司（以下简称"公司"）于 2025 年 6 月 10 日召开 第一届董事会第十九次会议和第一届监事会第十一次会议，审议通过了《关于使 用部分暂时闲置募集资金进行现金管理的议案》，同意公司（含实施募投项目的 子公司，下同）在确保不影响公司正常经营、不影响募集资金投资计划正常进行 及确保募集资金安全的前提下，使用最高不超过人民币 39,800.00 万元（单日最 高余额，含本数）的暂时闲置募集资金进行现金管理，用于购买安全性高、流动 性好的保本型产品（包括但不限于保本型理财产品、定期存款、通知存款、大额 存单、协定存款、结构性存款、收益凭证等）。在上述额度范围内，资金可以滚 动使用，使用期限自公司董事会审议通过之日起 12 个月内有效。具体内容详见公 司于上海证券交易所网站（www.sse.com.cn）披露的《关于使用部分暂时闲置募 集资金进行现金管理的公告》（公告编号：2025-0 ...

Key Insights - The report highlights an active new stock market in June 2025, with a total of 6 new stocks listed, and 33 stocks recorded positive growth over the past six months, representing 71.74% of the new listings [6][7] - In the coal industry, there is a significant decline in coal imports, with May 2025 showing a year-on-year decrease of 17.75% and a month-on-month decrease of 4.73%, indicating a trend of accelerated contraction [8][11] - The report discusses the innovative drug IBI363, which has shown promising clinical benefits in treating immune-resistant non-small cell lung cancer (NSCLC), colorectal cancer, and melanoma, with significant survival gains reported [10][12][15] Market Trends - The domestic market indices showed slight declines, with the Shanghai Composite Index closing at 3,454.79, down 0.09%, and the Shenzhen Component Index at 10,412.63, down 0.61% [4] - The coal import data indicates a continuous negative growth trend, with all coal types experiencing varying degrees of decline, except for a slight increase in thermal coal imports from Australia [8][11] Industry Commentary - The report provides insights into the coal industry's expansion behavior, particularly focusing on the "mining king" phenomenon, which reflects the market's attention on coal mining rights and their impact on asset pricing [14][16][17] - The report emphasizes the importance of resource pricing in guiding the valuation of coal companies, suggesting that companies with strong performance support and undervalued stocks should be closely monitored [18] Investment Recommendations - The report suggests focusing on coal companies that are significantly undervalued, particularly those with minimal non-coal business exposure, such as Panjiang Coal and Yancoal [18] - For the innovative drug IBI363, the report indicates a strong potential for market success due to its clinical efficacy in previously hard-to-treat cancers, which may attract investor interest [10][12][15]

Group 1 - In the first half of 2025, Jiangsu had 12 companies successfully listed on A-shares, leading the nation in IPO numbers [1][3] - Suzhou led the province with 4 newly listed companies, including notable firms such as Huazhi Jie and Zhongjie Automotive [2][3] - Jiangsu accounted for approximately 23.53% of the total 51 companies that went public on A-shares in the first half of 2025 [3] Group 2 - In addition to A-shares, 6 Jiangsu companies successfully listed on the Hong Kong Stock Exchange during the same period [3] - Jiangsu has nearly 60 companies waiting for approval to list on the Shanghai, Shenzhen, and Beijing exchanges, with over 20 companies queued for the Hong Kong Stock Exchange [4]

Core Insights - A total of 51 new companies were listed on the Shanghai Stock Exchange, Shenzhen Stock Exchange, and Beijing Stock Exchange from January to June 2025, raising a total of 37.3 billion yuan [1] - Among these, 7 companies were listed on the Sci-Tech Innovation Board, collectively raising 5.619 billion yuan [1] Listing Details - The 7 companies that chose the first set of listing standards include: - Ying Shi Innovation (688775.SH) listed on June 11, 2025, raising 1.93807 billion yuan with underwriting fees of 158.3475 million yuan [1] - Han Bang Technology (688755.SH) listed on May 16, 2025, raising 500.94 million yuan with underwriting fees of 37.2891 million yuan [1] - Sheng Ke Nano (688757.SH) listed on March 25, 2025, raising 366.21 million yuan with underwriting fees of 43.9448 million yuan [1] - Hai Bo Si Chuang (688411.SH) listed on January 27, 2025, raising 861.1 million yuan with underwriting fees of 66.4722 million yuan [1] - Xing Fu Electronics (688545.SH) listed on January 22, 2025, raising 1.168 billion yuan with underwriting fees of 82.0755 million yuan [1] - Si Kan Technology (688583.SH) listed on January 15, 2025, raising 568.82 million yuan with underwriting fees of 46.0744 million yuan [1] - Sai Fen Technology (688758.SH) listed on January 10, 2025, raising 215.89 million yuan with underwriting fees of 25.283 million yuan [1] Listing Standards - The listing standards for the Sci-Tech Innovation Board require either: - An expected market value of no less than 1 billion yuan, positive net profits for the last two years, and a cumulative net profit of no less than 50 million yuan, or - An expected market value of no less than 1 billion yuan, positive net profit for the last year, and operating revenue of no less than 100 million yuan [1]

Group 1 - The core viewpoint of the articles highlights the fundraising activities of companies listed on the STAR Market, with a total of 7 companies raising 7.901 billion yuan this year, averaging 1.129 billion yuan per company [1][2] - The company with the highest fundraising amount is Yitang Co., Ltd., which raised 2.497 billion yuan primarily for technology development and reserve funds [1] - Other notable companies include Yingshi Innovation, which raised 1.938 billion yuan for its R&D center and production base, and Xingfu Electronics, which raised 1.168 billion yuan [1] Group 2 - The average initial offering price for STAR Market stocks this year is 21.73 yuan, with Yingshi Innovation having the highest price at 47.27 yuan [1] - The issuance price of Yitang Co., Ltd. is the lowest at 8.45 yuan, while other companies like Sikan Technology and Hanbang Technology have initial prices of 33.46 yuan and 22.77 yuan respectively [1] - The issuance price-earnings ratio for the listed companies ranges from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] Group 3 - Geographically, the majority of the issued STAR Market companies are concentrated in Beijing, Jiangsu, and Hubei, with fundraising amounts led by Beijing at 3.359 billion yuan [2] - The companies with issuance price-earnings ratios above the industry average include Yitang Co., Ltd. and two others, while five companies fall below the industry average [2] - The detailed fundraising data for the listed companies includes their codes, names, issuance dates, prices, price-earnings ratios, and total funds raised [2]

Group 1 - The first meeting of the Supervisory Board of Jiangsu Hanbang Technology Co., Ltd. was held on June 17, 2025, with all three supervisors present [1] - The Supervisory Board approved the proposal to use raised funds to replace self-raised funds that were previously invested in projects and paid issuance expenses, totaling 56.548 million yuan [1] - The use of raised funds for this purpose will not affect the normal implementation of the fundraising projects and complies with relevant regulations [1][2] Group 2 - The voting result for the proposal was 3 votes in favor, 0 votes against, and 0 abstentions [2]